Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative medications function by mimicking the inherent actions of GLP-1, a hormone produced by https://atozbookmarkc.com/story20997171/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes